Locally advanced primary breast cancer: Medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy

European Journal of Cancer

Volumn 37, Issue 18, 2001, Pages 2331-2338

  Tan, S M ^a   Cheung, K L ^a   Willsher, P C ^a   Blamey, R W ^a   Chan, S Y ^a   Robertson, J F R ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Hormone therapy; Locally advanced primary breast cancer; Multimodal therapy

Indexed keywords

ESTROGEN RECEPTOR; GOSERELIN; MEGESTROL ACETATE; METHOTREXATE; MITOMYCIN; MITOXANTRONE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; METHOTREXATE; MIDDLE AGED; MITOMYCIN; MITOXANTRONE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035201505     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00298-2     Document Type: Article

References (18)

1. Carcinoma of the breast 2: Criteria for operability
2. Locally advanced breast cancer: Long term results of a randomised trial comparing primary treatment with tamoxifen or radiotherapy
3. Local advanced breast cancer: The contribution of cytotoxic and endocrine treatment to radiotherapy
4. Locally advance breast cancer: Early results of a randomised trial of multimodal therapy versus initial hormone therapy
5. Assessment of response to therapy in advanced breast cancer: A project of the Programme on Clinical Oncology of the International union Against Cancer, Geneva, Switzerland
6. Assessment of response to treatment in advanced breast cancer
7. Methodology of immunohistological detection of estrogen receptor in human breast carcinoma in formalin-fixed, paraffin-embedded tissue: A comparison with frozen section methodology
8. Multidisciplinary management of advanced primary and metastatic breast cancer
9. Randomised trial of chemotherapy versus endocrine therapy in patients presenting locally advanced breast cancer (a pilot study)
10. Primary medical (neoadjuvant) chemotherapy for operable breast cancer
11. Tamoxifen therapy in postmenopausal advanced breast cancer: Efficacy at the primary tumor site in 46 evaluable patients
12. Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer
13. Locally advanced breast cancer: Definig an optimum treatment
14. Tamoxifen alone versus surgery plus tamoxifen for breast cancer of the elderly. Meta-analysis of long term results of the GRETA and CRC trials
15. The management of locally advanced breast cancer: A combined modality approach
16. Multimodal treatment strategy for locally advanced breast cancer
17. Improving the quality of reporting of randomised controlled trials: The CONSORT statement